ERBB2 and breast cancer: Moreover, integrin β4 mediate indirect adhesion to the BE by driving HER2+ breast cancer cells to induce vascular endothelial growth factor (VEGF) expression, which in turn degrades tight and adherens protein junctions of BE (ZO-1, VE-cadherin) [35].